Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms

BJOG. 2015 Dec;122(13):1781-8. doi: 10.1111/1471-0528.13194. Epub 2014 Dec 4.

Abstract

Objective: To evaluate two algorithms for prediction of preeclampsia in a population of nulliparous women in Norway.

Design: Prospective screening study.

Setting: National Centre for Fetal Medicine in Trondheim, Norway.

Population: Five hundred and forty-one nulliparous women.

Methods: The women were examined between 11(+0) and 13(+6) weeks with interviews for maternal characteristics and measurements of mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein A and placental growth factor. The First Trimester Screening Program version 2.8 by The Fetal Medicine Foundation (FMF) was compared with the Preeclampsia Predictor TM version 1 revision 2 by Perkin Elmer (PREDICTOR).

Main outcome measures: Prediction of preeclampsia requiring delivery before 37 weeks, before 42 weeks and late preeclampsia (delivery after 34 weeks).

Results: The performance of the two algorithms was similar, but quite poor, for prediction of preeclampsia requiring delivery before 42 weeks with an area under the curve of 0.77 (0.67-0.87) and sensitivity 40% (95% CI 19.1-63.9) at a fixed 10% false positive rate for FMF and 0.74 (0.63-0.84) and sensitivity 30% (95% CI 11.9-54.3) at a fixed 10% false positive rate for PREDICTOR. The FMF algorithm for preeclampsia requiring delivery <37 weeks had an area under the curve of 0.94 (0.86-1.0) and sensitivity of 80% (95% CI 28.4-99.5) at a 10% fixed false positive rate.

Conclusions: Fetal Medicine Foundation and PREDICTOR algorithms had similar and only modest performance in predicting preeclampsia. The results indicate that the FMF algorithm is suitable for prediction of preterm preeclampsia.

Keywords: Biomarkers; Doppler; blood pressure; first trimester; preeclampsia; risk calculation; ultrasound; uterine artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Algorithms*
  • Female
  • Gestational Age
  • Humans
  • Norway
  • Parity
  • Placenta Growth Factor
  • Pre-Eclampsia / diagnosis*
  • Pre-Eclampsia / diagnostic imaging
  • Pregnancy
  • Pregnancy Proteins / metabolism
  • Pregnancy Trimester, First
  • Pregnancy-Associated Plasma Protein-A / metabolism
  • Prospective Studies
  • Pulsatile Flow
  • Risk Assessment / methods
  • Risk Factors
  • Ultrasonography, Prenatal
  • Uterine Artery / diagnostic imaging
  • Young Adult

Substances

  • PGF protein, human
  • Pregnancy Proteins
  • Placenta Growth Factor
  • Pregnancy-Associated Plasma Protein-A